DecisionGatewayβ
Feed Claims Forecasts Trajectories Domains Calendar Actors Places Blog
API Sign in
HomeClaimsThe FDA warns of the risk of permanent blindness with Ozempic, Wegovy and other weight-loss drugs.
allegation

The FDA warns of the risk of permanent blindness with Ozempic, Wegovy and other weight-loss drugs.

A allegation by fda. Statements are as reported by the cited publishers — not verified by DecisionGateway.

La FDA advierte del riesgo de ceguera permanente con Ozempic, Wegovy y otros fármacos para adelgazar.
diario_larazonPublished 2026-11-10 Read source
fda dossier

Discussion

0/2000 Ctrl/⌘ + Enter

Related claims

The FDA requires a warning about a risk of sudden blindness with popular weight-loss drugs.noticias_telemundo · statementThere is an official American warning about Ozempic and Zepbound concerning a rare risk to eyesight.تحذير أميركي رسمي · allegationPeople are suddenly losing their sight because of Ozempic and other popular weight-loss drugs.Yhdysvaltain FDA · allegationOzempic carries a rare risk to eyesight.تحذير أميركي رسمي · allegationWeight-loss drugs may increase the risk of irreversible vision loss.fda · allegationA new eye warning about taking Ozempic or Wegovy raises questions.gulfnewsuae · statement

More claims by fda

Weight-loss drugs may increase the risk of irreversible vision loss.allegation
All claims by fda
All claims
FeedActorsForecasts